Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study - PubMed (original) (raw)
Randomized Controlled Trial
Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study
John M Lachin et al. Diabetes Care. 2014.
Abstract
OBJECTIVE To describe the beneficial long-term effects of an average of 6.5 years of intensive diabetes therapy (INT) in type 1 diabetes on measures of atherosclerosis, cardiac structure and function, and clinical cardiovascular events observed in the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study. RESEARCH DESIGN AND METHODS The DCCT was a randomized clinical trial of 1,441 participants assigned to receive INT or conventional therapy (CON). It was conducted between 1983-1993 with an average follow-up of 6.5 years. EDIC (1994-present) is an observational follow-up of the DCCT cohort. Cardiovascular events have been recorded throughout. During EDIC common carotid intima-media thickness (IMT) was measured with ultrasound, coronary artery calcification with computed tomography, and cardiac structure and function with cardiac magnetic resonance imaging. RESULTS DCCT INT and lower levels of HbA1c during DCCT/EDIC were associated with thinner carotid IMT, less coronary calcification, and a lower incidence of clinical cardiovascular events including myocardial infarction, stroke, and cardiac death. While there were no significant differences in cardiac structure and function between the former INT and CON groups, they were significantly associated with higher HbA1c during DCCT/EDIC. CONCLUSIONS DCCT INT and the attendant 6.5 years of lower HbA1c had long-term salutary effects on the development and progression of atherosclerosis and cardiovascular disease during the subsequent follow-up during EDIC.
Figures
Figure 1
The mean level of the common carotid IMT within the INT and CON groups at EDIC year 1 and again at EDIC years 6 and 12. Reprinted with permission from Polak et al. (12).
Figure 2
The cumulative incidence of clinical CVD outcomes during DCCT/EDIC. A: Any qualifying primary outcome event. B: MACE. Reprinted with permission from Nathan et al. (9).
Similar articles
- Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
de Boer IH; DCCT/EDIC Research Group. de Boer IH, et al. Diabetes Care. 2014;37(1):24-30. doi: 10.2337/dc13-2113. Diabetes Care. 2014. PMID: 24356594 Free PMC article. Clinical Trial. - The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM; DCCT/EDIC Research Group. Cleary PA, et al. Diabetes. 2006 Dec;55(12):3556-65. doi: 10.2337/db06-0653. Diabetes. 2006. PMID: 17130504 Free PMC article. Clinical Trial. - Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes. 1999 Feb;48(2):383-90. doi: 10.2337/diabetes.48.2.383. Diabetes. 1999. PMID: 10334318 Free PMC article. Clinical Trial. - Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
Nathan DM. Nathan DM. Diabetologia. 2021 May;64(5):1049-1058. doi: 10.1007/s00125-021-05397-4. Epub 2021 Feb 6. Diabetologia. 2021. PMID: 33550441 Review.
Cited by
- Advanced cardiovascular physiology in an individual with type 1 diabetes after 10-year ketogenic diet.
Watso JC, Robinson AT, Singar SAB, Cuba JN, Koutnik AP. Watso JC, et al. Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C446-C461. doi: 10.1152/ajpcell.00694.2023. Epub 2024 Jun 24. Am J Physiol Cell Physiol. 2024. PMID: 38912731 - Glucose fluctuation promotes mitochondrial dysfunctions in the cardiomyocyte cell line HL-1.
Mordel P, Fontaine F, Dupas Q, Joubert M, Allouche S. Mordel P, et al. PLoS One. 2023 Sep 21;18(9):e0289475. doi: 10.1371/journal.pone.0289475. eCollection 2023. PLoS One. 2023. PMID: 37733770 Free PMC article. - Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis.
Conway RB, Gerard Gonzalez A, Shah VN, Geno Rasmussen C, Akturk HK, Pyle L, Forlenza G, Alonso GT, Snell-Bergeon J. Conway RB, et al. Diabetes Metab Syndr Obes. 2023 Aug 2;16:2295-2310. doi: 10.2147/DMSO.S416192. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37551339 Free PMC article. - Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes.
Castro Conde A, Marzal Martín D, Campuzano Ruiz R, Fernández Olmo MR, Morillas Ariño C, Gómez Doblas JJ, Gorriz Teruel JL, Mazón Ramos P, García-Moll Marimon X, Soler Romeo MJ, León Jiménez D, Arrarte Esteban V, Obaya Rebollar JC, Escobar Cervantes C, Gorgojo Martínez JJ. Castro Conde A, et al. J Clin Med. 2023 Jun 8;12(12):3925. doi: 10.3390/jcm12123925. J Clin Med. 2023. PMID: 37373620 Free PMC article. Review. - Exploring Racial and Ethnic Differences in Arterial Stiffness Among Youth and Young Adults With Type 1 Diabetes.
Sauder KA, Glueck DH, Harrall KK, D'Agostino R Jr, Dolan LM, Lane AD, Liese AD, Lustigova E, Malik FS, Marcovina S, Mayer-Davis E, Mottl A, Pihoker C, Reynolds K, Shah AS, Urbina EM, Wagenknecht LE, Daniels SR, Dabelea D. Sauder KA, et al. J Am Heart Assoc. 2023 Apr 4;12(7):e028529. doi: 10.1161/JAHA.122.028529. Epub 2023 Mar 30. J Am Heart Assoc. 2023. PMID: 36994741 Free PMC article.
References
- The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
- Lachin J, Genuth S, Nathan D, Davis M, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381–389 - PMC - PubMed
- Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN, DCCT/EDIC Research Group Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial—revisited. Diabetes 2008;57:995–1001 - PubMed
- Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159–2167 - PMC - PubMed
- Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006;29:2528–2538 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK094176/DK/NIDDK NIH HHS/United States
- U01-DK-094157/DK/NIDDK NIH HHS/United States
- UL1 TR000041/TR/NCATS NIH HHS/United States
- U01 DK094157/DK/NIDDK NIH HHS/United States
- U01-DK-094176/DK/NIDDK NIH HHS/United States
- UL1 TR000457/TR/NCATS NIH HHS/United States
- UL1 TR001449/TR/NCATS NIH HHS/United States
- UL1 TR000114/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical